You are here

A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Kyunggi-do, , 463-712 Korea, Republic of
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
4 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Rheumatoid Arthritis

- Adults: Treatment of active rheumatoid arthritis (RA) in adults when the response to
disease-modifying antirhematic drugs (DMARDs), including MTX, has been inadequate

- Children: Treatment of active polyarticular-course chronic active rheumatoid arthritis
in children aged 4 to 17 years who have had an inadequate response to, or whom have
proved intolerant of, MTX

Psoriatic Arthritis

- Active and progressive psoriatic arthritis (PsA) in adults who do not respond adequately
to previous DMARDs

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients to whom Enbrel is contraindicated as per the local labeling

- Patients with known hypersensitivity to Enbrel or any component of the product

- Patients with sepsis or risk of sepsis

- Patients with active infections including chronic or localized infections such as
tuberculosis. (Treatment of Enbrel should not be initiated.)

NCT00195403
Pfizer
Completed
A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Rheumatoid Arthritis
NCT03981900
All Genders
18+
Years
Multiple Sites
Systemic Lupus Erythematosus, Rheumatoid Arthritis
NCT03334851
All Genders
18+
Years
Multiple Sites
Crohn Desease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
NCT02925338
All Genders
6+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now